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Abstract 
The proteobacterial antimicrobial compound efflux (PACE) family of transport proteins was 
only recently described, and as such we are only just beginning to appreciate the range of 
functions and mechanism(s) of transport operating in these proteins. PACE family transport 
proteins can confer resistance to a range of biocides used as disinfectants and antiseptics, and 
are encoded by many important Gram-negative human pathogens. Genes encoding PACE 
family proteins are typically conserved in the core genomes of these bacterial species rather 
than on recently acquired mobile genetic elements, suggesting that they confer important core 
functions in addition to biocide resistance. Tertiary or quaternary structural information is not 
available for PACE family proteins. However, PACE proteins have several very highly 
conserved amino acid sequence motifs that are likely to be important for substrate transport. 
PACE proteins also display strong amino acid sequence conservation between their N- and C-
terminal halves, suggesting that they evolved by duplication of an ancestral protein comprised 
of two transmembrane helices. In light of their drug resistance functions in Gram-negative 
pathogens, PACE proteins should be the subject of detailed future investigation.  
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Introduction 
In the broadest sense, drug resistance may arise in actively growing bacterial cells in two 
distinct ways, either the drug target site is protected from the toxic activities of the drug by 
modification or bypass, or the drug can’t reach the target site due to degradation, sequestration, 
reduced cellular entry, or active efflux. Efflux is a major mechanism of drug resistance, and 
due to the high promiscuity in substrate recognition by the transport proteins involved, efflux 
mediated resistance is found for a wide range of different antimicrobial compounds.  
Bacterial drug efflux proteins from five distinct families of transport proteins were described 
between the 1970s and 2000 and have been studied extensively at both the functional and 
structural levels [7]. These families include the ATP-binding cassette (ABC) superfamily, the 
major facilitator superfamily (MFS), the resistance-nodulation-cell division (RND) 
superfamily, the multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) flippase superfamily, 
and the drug/metabolite transporter (DMT) superfamily. In the last five years two new 
transporter families that include bacterial drug efflux systems have been identified; these are 
the Proteobacterial Antimicrobial Compound Efflux (PACE) family and the p-Aminobenzoyl-
glutamate transporter (AbgT) family [12, 13, 22]. Proteins from the PACE family transport 
biocides such as chlorhexidine and acriflavine, whereas AbgT family transporters transport 
sulphonamides. 
The Acinetobacter baumannii AceI protein is a prototype for the novel PACE family of 
transport proteins 
Drug efflux systems, and drug resistance factors in general, are frequently controlled by 
regulators that can sense the transported drug substrates or their downstream effects in the cell. 
For example, TetR controls expression of the tetB tetracycline transporter gene in response to 
tetracyclines, and QacR controls expression of the multidrug efflux pump gene qacA in 
response to cationic antimicrobials [10]. For bacterial cells, this regulatory control means that 
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efflux pump gene expression will proceed only when the pumps are required, saving cellular 
resources and preventing the potential toxic effects of constitutive high-level efflux pump 
expression [1]. From a research perspective, this tight regulatory control of drug efflux pump 
genes means that transcriptional changes may be used to highlight efflux pumps that might 
recognise substrates of interest, or to identify novel factors that may be involved in drug 
resistance. 
The Acinetobacter chlorhexidine efflux protein (AceI) was identified by analysing the 
transcriptomic response of Acinetobacter baumannii to the membrane active biocide 
chlorhexidine [12, 11]. Chlorhexidine is listed as an essential medicine by the World Health 
Organisation, and is commonly used as an antiseptic in wound dressings, hand washes and 
mouthwashes. The transcriptome of A. baumannii ATCC 17978 cells exposed to a sub-
inhibitory concentration of chlorhexidine, equivalent to half the minimum inhibitory 
concentration, was compared to control cells. The major gene expression changes were to genes 
encoding the AdeAB components of the AdeABC multidrug efflux pump and a gene annotated 
as encoding a hypothetical protein, A1S_2063 [12].  
From its sequence the A1S_2063 gene was predicted to encode an inner-membrane protein with 
four transmembrane helices (Figure 1A). The gene was cloned into an E. coli expression vector 
and was shown to confer significant levels of resistance to chlorhexidine when overexpressed 
in E. coli. Deletion of the A1S_2063 gene in A. baumannii ATCC 17978 and its ortholog in 
Acinetobacter baylyi ADP1, resulted in a halving of chlorhexidine resistance in the host strain, 
demonstrating the genes had a resistance function in native hosts [12, 23]. The Biolog 
Phenotype Microarray system was used to determine whether the A1S_2063 gene could confer 
resistance to more than 200 other antimicrobials. These assays demonstrated an apparent 
specificity of A1S_2063 for chlorhexidine [12]. 
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When overexpressed in E. coli the A1S_2063 protein product was identified in the inner 
membrane. The protein could be readily extracted from the membrane by detergent 
solubilisation and purified. The detergent solubilised protein was found to bind to chlorhexidine 
with high affinity (Kd in the low M range) as determined by tryptophan fluorescence 
quenching and near-UV synchrotron radiation circular dichroism [12]. Transport experiments 
using [14C]-chlorhexidine demonstrated that the A1S_2063 protein prevented the high-level 
accumulation of chlorhexidine when expressed in E. coli, until the cells were de-energised using 
a protonophore, and could mediate the efflux of chlorhexidine from E. coli cells pre-loaded 
with chlorhexidine [12]. Together these results suggested that the A1S_2063 protein was a 
novel chlorhexidine efflux protein, which was named AceI (Acinetobacter chlorhexidine efflux 
protein I).  
PACE proteins are a family of multidrug efflux systems conserved across many Gram-
negative pathogens 
Genes encoding proteins homologous to AceI are found in the genomes of many bacterial 
species. These genes are particularly common among Proteobacteria, but can be found in some 
Actinobacteria and in a limited number of other unrelated bacterial species. To determine 
whether, like AceI, these proteins can mediate chlorhexidine resistance, more than 20 
phylogenetically diverse homologs were cloned into an E. coli expression system and examined 
by routine minimum inhibitory concentration analyses. Most of the cloned proteins were 
expressed at detectable levels, and about half could confer resistance to chlorhexidine [13]. 
Notably, at least two of the aceI homolgs found to confer chlorhexidine resistance, are also 
highly expressed in their native hosts, Pseudomonas aeruginosa and Burkholderia 
cenocepacia, in response to chlorhexidine treatment [17, 5]. 
Additional resistance tests were performed to determine whether the antimicrobial recognition 
profiles of these homologs might extend beyond chlorhexidine. Many of the proteins were able 
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to confer resistance to several additional biocides, including acriflavine, proflavine, 
benzalkonium and dequalinium [13]. The substrate profile of one pump, VP1155 encoded by 
Vibrio parahaemolyticus, was investigated using the Biolog phenotype microarray system. In 
addition to chlorhexidine, benzalkonium, proflavine and acriflavine, this analysis suggested 
that VP1155 could confer resistance to 9-aminoacridine, domiphen bromide, guanazole and 
plumbagin [13].  
The demonstration that many AceI homologs are able to confer resistance to compounds such 
as proflavine and acriflavine presented the possibility of assaying transport by measuring their 
fluorescence in real time [24]. These compounds intercalate into nucleic acids, which leads to 
a quenching of their fluorescence. This property facilitates a convenient assay for their transport 
in cells expressing an efflux pump [2]. Cells expressing the protein of interest can be loaded 
with proflavine or acriflavine in the presence of a protonophore, such as carbonyl cyanide m-
chlorophenylhydrazone (CCCP), then washed and re-energised by the addition of an energy 
source, such as D-glucose. Fluorescence can be monitored before and after energisation to 
examine transport [24]. These transport experiments have been performed for a number of AceI 
homologs and identified proteins that mediate transport of these compounds. For example, the 
B. cenocepacia HI2424 homolog Bcen2424_2356 is able to transport acriflavine, whereas at 
least one other homolog encoded by this strain, Bcen2424_5347, does not (Figure 2). 
Bcen2424_2356 has been previously shown to confer resistance to chlorhexidine, 
benzalkonium, proflavine and acriflavine. The Biolog phenotype microarray antimicrobial 
resistance tests confirmed several of these phenotypes and suggested that Bcen2424_2356 also 
confers resistance to benzethonium, 9-aminoacridine, methyl viologen, guanazole and 
plumbagin (Supplemental Figure S1). 
The observation that several AceI homologs can confer resistance to multiple biocides, and can 
mediate transport of the fluorescent substrates, proflavine and acriflavine, lead to their 
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designation as a new family of efflux pumps. This family was called the Proteobacterial 
Antimicrobial Compound Efflux (PACE) family, due to their abundance in Proteobacteria [13]. 
Proteins from this family have been incorporated into the Transporter Classification Database 
[20] under the original family title, the Proteobacterial chlorhexidine efflux (CHX) family 
(TCDB number: 2.A.117), and are captured in the TransportDB 2.0 database [8], which 
catalogues all putative transport proteins from sequenced genomes in the NCBI RefSeq 
database. 
Predicted topology and sequence conservation in PACE pumps 
All PACE family proteins analysed to date are predicted to contain four transmembrane -
helices, organised into two tandem bacterial transmembrane pair (BTP) domains (Figure 1; 
pfam: PF05232) [9]. Given their small size, it seems very likely that PACE proteins function 
as oligomers. However, the oligomeric state of PACE family proteins remains unresolved. 
Several PACE family proteins have been experimentally characterised by overexpression and 
purification (Henderson et al., unpublished). When expressed in E. coli these proteins localise 
to the inner-membrane and can be readily purified by extraction with a mild detergent such as 
n-dodecyl--D-maltoside [12], or using styrene maleic acid co-polymer (Supplemental Figure 
S2) [15]. Analysis of the purified detergent-solubilised proteins by far-UV circular dichroism 
has confirmed their high -helical content and demonstrated that they typically show structural 
stability to around 50-60 C. 
A high level of amino acid sequence conservation is apparent between members of the PACE 
family (Supplemental Figure S3). Two amino acid residues appear to be universally conserved 
across these proteins, a glutamic acid residue within transmembrane helix 1 and an alanine 
residue at the periplasmic/membrane boundary of transmembrane helix 4 (bold upper case font 
in Figure 1A). The functional importance of the conserved alanine has not yet been investigated, 
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but neutralisation of the glutamic acid residue in the prototypical PACE family member AceI 
by substitution with a glutamine abolished chlorhexidine resistance and transport [12]. 
However, this mutant (E15Q) was still able to bind chlorhexidine with only slightly reduced 
affinity compared to the parental protein. Furthermore, the mutant protein was less thermostable 
than the parental protein in the absence of substrate, but was significantly more stable than the 
parental protein in the presence of a molar excess of chlorhexidine. These results suggested that 
the glutamic acid residue is involved in an aspect of transport unrelated to substrate binding, 
possibly a proton coupling reaction. 
PACE family proteins contain several highly conserved amino acid residues in addition to the 
two universally conserved residues. The amino acid sequence conservation is particularly 
strong close to the predicted cytoplasmic boundaries of the transmembrane helices, where four 
amino acid sequence motifs have been identified (Figure 1). In line with the PACE proteins 
containing tandem BTP domains, the amino acid sequence motif in transmembrane helix 1 
(motif 1A; RxxhaxxfE, where upper case residues are conserved in more than 90% of proteins 
and lower case residues in at least 65% of proteins) is very similar to that in transmembrane 
helix 3 (motif 1B; RxxHaxxFe) (Figures 1B and 1C), and the motif in transmembrane helix 2 
(motif 2A, WNxxy/fNxxFd) is very similar to that in transmembrane helix 4 (motif 2B; 
Yxxxf/ynwxyD) (Figures 1D and 1E). The notable features of the sequence motifs in helices 1 
and 3 are the membrane embedded glutamic acid residue (universally conserved in helix 1), 
and histidine and arginine residues at the membrane boundary. The motifs found in helices 2 
and 4 notably contain several aromatic residues along one helical face adjacent to polar 
asparagine residues, and an aspartate residue at the membrane boundary (Figure 1A). 
Based on the distribution of charged residues within the loop regions, the N- and C-termini of 
most PACE family proteins are predicted to lie within the cytoplasm (Figure 1). However, some 
PACE family homologs, primarily from Acetobacter, contain predicted N-terminal signal 
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sequences, suggesting that the N-terminus is moved across the cytoplasmic membrane, and that 
they may exist in an alternative topology, e.g., APA01_04520 and APO_1949 from A. 
pasteurianus IFO 3283-01 and A. pomorum DM001, respectively. Representatives of these 
proteins have been expressed in E. coli, but as yet, no resistance or transport functions have 
been identified (Hassan et al., unpublished). These proteins may be defined in a separate protein 
sub-family from those that mediate drug resistance in the future.  
Conservation of PACE family genes  
PACE family proteins are typically highly conserved in the genome of their encoding bacterial 
species. For example, genes encoding three different PACE proteins have been identified in the 
A. baumannii pan-genome (based on the genomes of 623 strains) [11]. Of these two were 
conserved in 100% or close to 100% of the strains and can be considered to be part of the core 
genome. The third gene was found in only two strains and is part of the accessory genome. 
Similar to A. baumannii, Pseudomonas aeruginosa isolates have two PACE proteins encoded 
in the core genome and one in the accessory genome, which is found in only a few strains, and 
B. cenocepacia strains encode three PACE pumps in their core genome [11]. This high level of 
conservation suggests that PACE pumps are acquired vertically and have been maintained in 
their host species since their divergence from related organisms. As such they are likely to have 
an important core function that may be unrelated to drug resistance. Indeed, the biocides that 
are recognised by PACE family pumps have only been present in the environment for 50-100 
years, and are thus very unlikely to be the physiological substrates of these proteins. 
In contrast to the species described above E. coli do not encode PACE pumps in their core 
genomes; four different genes encoding PACE homologs were found among the genomes of 
1986 sequenced E. coli strains, but these were each found in 0.2% of strains or less [11]. These 
accessory genes are likely to move between related species on mobile genetic elements. 
However, there is as yet no strong evidence for how these genes are mobilised. 
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Evolution of the PACE family 
The conservation of sequence motifs between the N- and C-terminal halves of PACE proteins 
suggests that these proteins may have evolved by a duplication event of an ancestral single BTP 
domain protein. To investigate this further, the N- and C-terminal BTP domains were compared 
between 48 diverse PACE family proteins (Supplemental Figure S4). The level of amino acid 
sequence similarity between the N- and C-terminal BTP domains in these proteins ranged from 
26% to 57% (mean 47%). The presence of such high levels of sequence conservation between 
the N- and C-terminal BTP domains across diverse PACE family proteins suggests that these 
proteins have not diverged significantly since the occurrence of the duplication event(s). Along 
with the distribution of these proteins almost exclusively within the Proteobacteria, and their 
likely vertical acquisition, due to their presence on the core genome, this may suggest that this 
protein family is relatively young compared to other families of transport proteins, which show 
lower levels of sequence conservation between domains that are thought to have arisen via 
duplication [19]. 
To examine further the evolution of PACE family proteins, the levels of sequence similarity 
between the N-terminal and C-terminal BTP domains of different PACE proteins were 
determined. It was found that the N-terminal BTP domains of PACE family proteins are almost 
always more similar to the N-terminal BTP domains of other PACE proteins than they are to 
their own C-terminal BTP domain, or the C-terminal BTP domain of other PACE family pumps 
(Supplemental Figure S4). This suggests that a BTP domain duplication event occurred only 
once in an ancestral gene, and that there is little or no recombination between the N- and C-
terminal BTP domains in individual strains. The C-terminal BTP domains of different PACE 
pumps typically show even higher levels of sequence similarity than the N-terminal domains 
(Supplemental Figure S4). The high conservation of sequence within the C-terminal domain of 
 11 
different proteins may reflect the involvement of the C-terminal domain in a core part of the 
functional mechanism. 
Concluding remarks 
The PACE family of transport proteins is one of two transporter families discovered only 
recently to mediate drug efflux. From currently available analyses PACE family proteins 
display somewhat restricted drug substrate recognition profiles, which include primarily 
synthetic biocides such as chlorhexidine and acriflavine, rather than the multitudes of diverse 
antibiotics and biocides recognised by transport proteins from families such as the RND 
superfamily. This may be a primary reason for the family being only recently identified, 15 
years after the first descriptions of MATE family pumps [16, 3]. However, PACE proteins are 
highly conserved in a range of opportunistic Gram-negative pathogens, including A. baumannii, 
P. aeruginosa, B. cenocepacia and Klebsiella pneumoniae, and in serious human pathogens 
such as Yersinia pestis, Francisella tularensis, and Burkholderia pseudomallei. Therefore, the 
role of these proteins in drug resistance warrants future investigation. 
As mentioned above the drug recognition profile of PACE pumps includes primarily synthetic 
biocides, most of which have only been in the environment for 50-100 years. However, genes 
encoding homologous PACE family proteins are found in the core genomes of bacterial genera 
that diverged much earlier than this, hundreds of millions of years ago. Therefore, these proteins 
are likely to mediate an important core function and may have common physiological substrates 
that are yet to be described. The importance of PACE family proteins is likely to extend beyond 
an apparently fortuitous role in drug resistance.  
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Figure 1. Predicted transmembane topology and conserved amino acid sequent motifs present 
in PACE family proteins. An amino acid sequence alignment of 48 diverse PACE family 
proteins (Supplemental Figure 1), encoded by a broad range of hosts, was used to identify amino 
acid sequence motifs that are conserved across the family. (A) Predicted topology of PACE 
family proteins. Coloured and bold upper case characters are conserved in 100% of the aligned 
sequence. Upper case characters are conserved in greater than 90% of protein sequences and 
characters in lower case are conserved in greater than 65% but fewer than 90% of the aligned 
protein sequences. Amino acid sequence motifs are encompassed by lines and labelled. (B-D) 
Sequence logos, made using WebLogo [6], showing conservation of amino acid residues in the 
four sequence motifs identified in PACE proteins. 
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Figure 2. Acriflavine transport mediated by PACE family proteins encoded by the human 
pathogen Burkholderia cenocepacia HI2424. A) Transport experiments performed using E. coli 
OmniMax cells expressing the proteins of interest, essentially as described previously [13]. The 
cells were pre-loaded with 5 M acriflavine in the presence of 10 M CCCP. The cells were 
washed and re-energised using glucose at the point marked with an arrow and transport 
monitored fluorimetrically. Acriflavine fluorescence is quenched when it is intercalated into 
nucleic acids. Therefore, its transport out of the cell is associated with an increase in 
fluorescence. B) Western blot performed on the cells used in the assay, probed using His-Probe-
HRP. The B. cenocepacia HI2424 PACE family proteins Bcen2424_2356 and Bcen2424_5347, 
were expressed at easily detectable levels after the one hour induction used for this assay. 
Bcen2424_2356 promoted the rapid efflux of acriflavine, whereas Bcen2424_5347 did not 
promote acriflavine transport above the background level. Bcen2424_5167 was not expressed 
or expressed very poorly. Bcen2424_5167 and Bcen2424_5347 are phylogenetically distinct 
from Bcen2424_2356. The error bars show the standard deviation of three replicate 
experiments. 
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Supplemental materials 
Figure S1. Kinetic response curves paralleling bacterial growth for Biolog phenotype 
microarray antimicrobial tests in which the pTTQ18-Bcen2424_2356 plasmid facilitated a 
growth advantage. Curves for E. coli BL21 cells carrying pTTQ18 are shown in red, curves for 
BL21 cells carrying pTTQ18-Bcen2424_2356 are shown in green, and regions of overlap in 
the response curves of these two strains are shown in yellow. The tests were conducted 
according to the manufacturer’s instructions in the presence of 0.05 mM IPTG to promote 
expression of the cloned Bcen2424_2356 gene. The curves depict the color intensity of a redox-
active dye (y axis) over time (x axis; 30 h). (A) plate PM12, well E12 (benzethonium chloride) 
(B) plate PM14, well A3 (acriflavine), (C) plate PM14, well B3 (9-aminoacridine), (D) plate 
PM15, well E11 (methyl viologen), (E) plate PM18, well G7 (3,5-diamino-1,2,4-triazole 
[guanazole]), (F) plate PM18, well H12 (plumbagin), (G) plate PM19, well C4 (chlorhexidine). 
Figure S2. Purification of the Ferrimonas balearica DSM 9799 PACE family protein, 
Fbal_3166 [13], using styrene maleic acid co-polymer. Fbal_3166 protein was overexpressed 
in E. coli BL21 cells grown in a 30 L fermenter using the pTTQ18 expression system [25, 21]. 
Styrene maleic acid co-polymer preparation, membrane solubilisation and Ni-affinity 
purification were performed as previously described [15]. Samples consisting of solubilised 
membrane proteins (lane A), proteins that did not bind to the Ni-affinity column (lane B), and 
purified Fbal_3166 (lane C) were run on a 15% SDS-PAGE gel and stained with coomassie 
brillian blue R-250. The size (KDa) of co-migrated soluble molecular weight markers is show 
on the left side of the gel.  
Figure S3. Amino acid sequence alignment of 48 diverse PACE family proteins. Sequences 
were obtained from the NCBI genomes database and aligned using ClustalX [14]. The 
alignment is coloured according to the level of amino acid sequence conservation at each 
position, colours were added using the UGENE toolkit [18].  
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Figure S4. Pairwise comparisons of the individual BTP domains in 48 diverse PACE family 
proteins. The amino acid sequences of the separated domains were analysed using the MatGat 
tool [4] to determine the percent similarity (A) and percent identity (B) between each domain. 
The top right region of each plot shows comparisons between the N-terminal BTP domains of 
different proteins, and the bottom left region of each plot shows comparisons between the C-
terminal BTP domains of different proteins. The central regions of each plot, surrounded by 
large boxes, represent comparisons between the N-terminal domains and C-terminal domains 
of the proteins. The small boxes within these regions highlight comparisons between the N- and 
C-terminal domains of the same protein. 
